Literature DB >> 10666170

Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging.

M Bollow1, T Fischer, H Reisshauer, M Backhaus, J Sieper, B Hamm, J Braun.   

Abstract

OBJECTIVE: Sacroiliitis is a hallmark of the spondyloarthropathies (SpA). The degree of inflammation can be quantified by magnetic resonance imaging (MRI). The aim of this study was to further elucidate the pathogenesis of SpA by quantitative cellular analysis of immunostained sacroiliac biopsy specimens and to compare these findings with the degree of enhancement in the sacroiliac joints (SJ) as detected by dynamic MRI.
METHODS: The degree of acute sacroiliitis detected by MRI after intravenous administration of gadolinium-DTPA was quantitatively assessed by calculating the enhancement observed in the SJ and chronic changes were graded as described in 32 patients with ankylosing spondylitis (n=18), undifferentiated SpA (n=12) and psoriatic arthritis (n=2). Back pain was graded on a visual analogue scale (VAS, 0-10) and disease duration (DD) was assessed. Shortly after MRI, SJ of patients with VAS > 5 were biopsied guided by computed tomography. Immunohistological examination was performed using the APAAP technique; only whole sections > 3 mm were counted.
RESULTS: By MRI, chronic changes </= grade II were detected in nine patients (group I, DD 2.5 (SD 2.9) years) and > II in 13 patients (group II, DD 7.3 (SD 4.8) years), while enhancement < 70% was found in eight (group A, DD 5.6 (SD 3.3) years) and > 70% in 12 patients (group B, DD 4.7 (SD 5.8) years). The relative percentage of cartilage (78-93%), bone (7-18%) and proliferating connective tissue (1-4%) was comparable between the groups (range). There were more inflammatory cells in group I compared with group II (mean (SD) 26.7(20.1) versus 5.3 (5. 2), p=0.04) and group A compared with B (21.8 (17.3) versus 6.0 (5. 6), p=0.05) cells/10 mm(2)), T cells (10.9 (8.5)) being slightly more frequent than macrophages (9.6 (16.8/10 mm(2))). Clusters of proliferating fibroblasts were seen in three and new vessel formation in seven cases.
CONCLUSION: This study shows that T cells and macrophages are the most frequent cells in early and active sacroiliitis in SpA. The correlation of cellularity and MRI enhancement provides further evidence for the role of dynamic MRI to detect early sacroiliitis.

Entities:  

Mesh:

Year:  2000        PMID: 10666170      PMCID: PMC1753076          DOI: 10.1136/ard.59.2.135

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

2.  Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study.

Authors:  Y Maugars; C Mathis; J M Berthelot; C Charlier; A Prost
Journal:  Br J Rheumatol       Date:  1996-08

Review 3.  The sacroiliac joint in the spondyloarthropathies.

Authors:  J Braun; J Sieper
Journal:  Curr Opin Rheumatol       Date:  1996-07       Impact factor: 5.006

4.  Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

Authors:  J Braun; M Bollow; G Remlinger; U Eggens; M Rudwaleit; A Distler; J Sieper
Journal:  Arthritis Rheum       Date:  1998-01

5.  Magnetic resonance imaging (MRI) for detection of active sacroiliitis--a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI.

Authors:  U Blum; C Buitrago-Tellez; A Mundinger; T Krause; J Laubenberger; P Vaith; H H Peter; M Langer
Journal:  J Rheumatol       Date:  1996-12       Impact factor: 4.666

6.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

7.  Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.

Authors:  J Braun; M Bollow; L Neure; E Seipelt; F Seyrekbasan; H Herbst; U Eggens; A Distler; J Sieper
Journal:  Arthritis Rheum       Date:  1995-04

8.  Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients.

Authors:  J Braun; M Bollow; U Eggens; H König; A Distler; J Sieper
Journal:  Arthritis Rheum       Date:  1994-07

9.  Early sacroiliitis in patients with spondyloarthropathy: evaluation with dynamic gadolinium-enhanced MR imaging.

Authors:  M Bollow; J Braun; B Hamm; U Eggens; A Schilling; H König; K J Wolf
Journal:  Radiology       Date:  1995-02       Impact factor: 11.105

Review 10.  Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both?

Authors:  J Sieper; J Braun
Journal:  Arthritis Rheum       Date:  1995-11
View more
  90 in total

Review 1.  Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences.

Authors:  J Braun; J Xiang; J Brandt; H Maetzel; H Haibel; P Wu; S Kohler; M Rudwaleit; S Siegert; A Radbruch; A Thiel; J Sieper
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy.

Authors:  J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 3.  Pathogenesis of reactive arthritis.

Authors:  J Sieper
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

Review 4.  Advances in the understanding of entheseal inflammation.

Authors:  Dennis McGonagle; Michael Benjamin; Helena Marzo-Ortega; Paul Emery
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

5.  Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems.

Authors:  J Braun; X Baraliakos; W Golder; K-G Hermann; J Listing; J Brandt; M Rudwaleit; S Zuehlsdorf; M Bollow; J Sieper; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2004-04-05       Impact factor: 19.103

6.  [Bone marrow edema in magnetic resonance imaging. A misleading term?].

Authors:  O W Hamer; J Kriegsmann
Journal:  Z Rheumatol       Date:  2012-01       Impact factor: 1.372

Review 7.  Biomarkers in spondyloarthritis.

Authors:  Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

8.  18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis.

Authors:  Klaus Strobel; Dorothee R Fischer; Giorgio Tamborrini; Diego Kyburz; Katrin D M Stumpe; Rolf G X Hesselmann; A Johayem; Gustav K von Schulthess; Beat A Michel; Adrian Ciurea
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-27       Impact factor: 9.236

9.  Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study.

Authors:  Dongyi He; Qi Zhu; Quan Zhou; Qing Qi; Hongmei Sun; Liza M Zachariah; Grace Wang; John D Reveille; Yongtao Guan; Xiaodong Zhou
Journal:  Clin Rheumatol       Date:  2017-04-22       Impact factor: 2.980

10.  [Spondylarthritides].

Authors:  J Braun; J Sieper
Journal:  Z Rheumatol       Date:  2006-11       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.